Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Shiwali Goyal
    Junior Member
    • Aug 2015
    • 9

    #1

    Concentration of lambda dna

    when i checked the qubit concentration of lambda dna (250microgram/microliter), the following readings occurs
    in 1:100 dilution the readings are 0.246ng/µl, 0.236ng/µl, 0.244ng/µl
    in 1:50 dilution the readings are 0.376ng/µl, 0.358ng/µl, 0.360ng/µl
    Since in 1:50 dilution the readings should come almost double of 1:100
    is there any fault in lambda dna as it is expired but its 1:100 concentration is perfect or any fault in qubit.
    thanks in advance
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    250 ug/ul seems very high. 100x dilution of such stock should be 2.5 ug/ul and 50x dilution 5 ug/ul not the figures you have got. If you are using the same stock at the same time for both dilutions then concentration of 50x dilution should be twice as 100x dilution regardless of DNA quality. There could be some issues with pipette or pipetting.

    Comment

    • Shiwali Goyal
      Junior Member
      • Aug 2015
      • 9

      #3
      Thank u so much

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 07:41 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...